M. Fujio

发表

Neuroprotective effects of a novel water-soluble poly(ADP-ribose) polymerase-1 inhibitor, MP-124, in in vitro and in vivo models of cerebral ischemia

S. Yuki, Y. Egi, Shigeru Matsuura, 2011, Brain Research.

(+)-3-[2-(Benzo[b]thiophen-2-yl)-2-oxoethyl]-1-azabicyclo[2.2.2]octane as potent agonists for the alpha7 nicotinic acetylcholine receptor.

K. Seio, K. Hashimoto, Hiroshi Tanaka, 2004, Bioorganic & medicinal chemistry letters.

Discovery of the alpha7 nicotinic acetylcholine receptor agonists. (R)-3'-(5-Chlorothiophen-2-yl)spiro-1-azabicyclo[2.2.2]octane-3,5'-[1',3']oxazolidin-2'-one as a novel, potent, selective, and orally bioavailable ligand.

K. Hashimoto, Hiroshi Tanaka, M. Fujio, 2005, Journal of medicinal chemistry.

(R)-3'-(3-methylbenzo[b]thiophen-5-yl)spiro[1-azabicyclo[2,2,2]octane-3,5'-oxazolidin]-2'-one, a novel and potent alpha7 nicotinic acetylcholine receptor partial agonist displays cognitive enhancing properties.

A. Numata, K. Hashimoto, Hiroshi Tanaka, 2006, Journal of medicinal chemistry.

Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria

I. Wilson, Chi‐Huey Wong, B. Beutler, 2006, Nature Immunology.

Glycolipids as immunostimulating agents.

Chi‐Huey Wong, Douglass Wu, M. Fujio, 2008, Bioorganic & medicinal chemistry.

Synthesis and evaluation of [125I]I-TSA as a brain nicotinic acetylcholine receptor alpha7 subtype imaging agent.

Y. Magata, M. Ogawa, M. Fujio, 2006, Nuclear medicine and biology.

in airway neutrophilia

Chi‐Huey Wong, P. Savage, C. Paget, 2007 .

Natural Sphingomonas glycolipids vary greatly in their ability to activate natural killer T cells.

Chi‐Huey Wong, M. Kronenberg, P. Seeberger, 2008, Chemistry & biology.

Potent immune-modulating and anticancer effects of NKT cell stimulatory glycolipids

Chi‐Huey Wong, Y. Tsai, Jing-Rong Huang, 2007, Proceedings of the National Academy of Sciences.

Design of a potent CD1d-binding NKT cell ligand as a vaccine adjuvant

D. Ho, Chi‐Huey Wong, S. Vasan, 2010, Proceedings of the National Academy of Sciences.

NKT cells sense bacterial infection and recognize bacterial glycolipids

N. Nagarajan, I. Wilson, Chi‐Huey Wong, 2007 .

Enantio- and diastereoselective construction of 4,9-dimethylspiro[4.4]nonane-2,7-dione using Rh-catalyzed asymmetric cyclization

Masakazu Tanaka, K. Sakai, H. Suemune, 2001 .

1,5-Benzodioxepin derivatives as a novel class of muscarinic M3 receptor antagonists.

H. Sakashita, M. Fujio, S. Sonda, 2007, Bioorganic & medicinal chemistry letters.

Identification of an IL-17–producing NK1.1neg iNKT cell population involved in airway neutrophilia

Chi‐Huey Wong, P. Savage, C. Paget, 2007, The Journal of experimental medicine.

Design of natural killer T cell activators: structure and function of a microbial glycosphingolipid bound to mouse CD1d.

I. Wilson, Chi‐Huey Wong, D. Zajonc, 2006, Proceedings of the National Academy of Sciences of the United States of America.

Structural evaluation of potent NKT cell agonists: implications for design of novel stimulatory ligands.

Chi-Huey Wong, Ian A Wilson, I. Wilson, 2009, Journal of molecular biology.

Structure-based discovery of glycolipids for CD1d-mediated NKT cell activation: tuning the adjuvant versus immunosuppression activity.

D. Ho, Chi‐Huey Wong, M. Tsuji, 2006, Journal of the American Chemical Society.

Quantitative microarray analysis of intact glycolipid-CD1d interaction and correlation with cell-based cytokine production.

Chi‐Huey Wong, Xiangming Li, M. Tsuji, 2008, Journal of the American Chemical Society.

Solvolysis of 1-(4-Methoxyphenyl)-1-aryl-2,2,2-trifluoroethyl Chlorides

M. Mishima, Y. Tsuno, M. Fujio, 1996 .

Substituent Effects on the Solvolysis of 2,2,2‐Trifluoro‐1,1‐diphenylethyl Tosylates. Part 2. 3‐Chlorophenyl‐ and 3,5‐Dichlorophenyl‐Fixed Systems

Y. Tsuno, M. Fujio, H. Morimoto, 1998 .

Substituent Effects. Part 22. The Solvolysis of α‐tert.‐Butylbenzyl Tosylates.

Y. Tsuno, M. Fujio, Y. Tsuji, 1990 .

N-[1-(2-Phenylethyl)pyrrolidin-3-yl]-1-adamantanecarboxamides as novel 5-HT2 receptor antagonists.

M. Fujio, Y. Sakai, T. Kuroita, 2000, Bioorganic & medicinal chemistry letters.

N‐[1‐(2‐Phenylethyl)pyrrolidin‐3‐yl]‐1‐adamantanecarboxamides as Novel 5‐HT2 Receptor Antagonists.

M. Fujio, Y. Sakai, T. Kuroita, 2001 .

N-[[1-(2-phenylethyl)pyrrolidin-2-yl]methyl]cyclohexanecarboxamides as selective 5-HT1A receptor agonists.

M. Fujio, J. Katayama, T. Kuroita, 2000, Bioorganic & medicinal chemistry letters.

Synthesis and evaluation of 11C-labeled (S)-N-{[1-(2-phenylethyl) pyrrolidin-2-yl]methyl}-3-methylthiobenzamide as a PET 5-HT1A receptor ligand

K. Ishiwata, K. Kawamura, S. Nagata, 2002 .

11C-labeling of (S)-N-{[1-(2-phenylethyl)pyrrolidin-2-YL]methyl}-3-methylthiobenzamide as a pet 5-HT1A receptor ligand

K. Ishiwata, K. Kawamura, S. Nagata, 2001 .

N‐{[1‐(2‐Phenylethyl)pyrrolidin‐2‐yl]methyl}cyclohexanecarboxamides as Selective 5‐HT1A Receptor Agonists.

M. Fujio, J. Katayama, T. Kuroita, 2000 .

Brief Definitive Report Identifi Cation of an Il-17–producing Nk1.1 Neg Inkt Cell Population Involved in Airway Neutrophilia

Chi‐Huey Wong, P. Savage, C. Paget, 2022 .